When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARDS - Amarin's Patent Infringement Lawsuit And Other News: The Good Bad And Ugly Of Biopharma
Aridis Pharmaceuticals Inc.
Amarin (AMRN) is fast approaching a significant event as the company’s lawsuit against a couple of generic drug makers is scheduled for trial on January 13, 2020. The main counter parties in this case are Dr. Reddy’s Laboratories (RDY), Hikma Pharmaceuticals (HKMPF) and Teva (TEVA), among others. While the case has been pending since 2016 in the district court in Nevada, the history of these claims goes back even farther, when In 2014, Amarin filed a patent infringement case against Dr. Reddy’s Laboratories alleging that its ANDA for marketing the generic version of